# Inherited burden for disease predisposition in diverse populations

**Authors:** Barış Kayaalp, Meltem Ece Kars, Yuval Itan, Ayşe Nazlı Başak, Jean-Laurent Casanova, Tayfun Özçelik

PMC · DOI: 10.1038/s41525-026-00552-5 · 2026-02-18

## TL;DR

This study explores inherited genetic variants linked to disease risk in diverse populations, showing how personalized medicine could help prevent disease and improve health.

## Contribution

The study expands the catalog of pathogenic and likely pathogenic variants by nearly six-fold using multiple genomic datasets.

## Key findings

- On average, individuals are born with 4.70 pathogenic or likely pathogenic variants.
- 1 in 11 individuals has an actionable genotype for potential disease prevention.
- 382 genes are identified as candidates for carrier screening.

## Abstract

We leveraged allele frequencies from gnomAD, Regeneron Genetics Center Million Exome and Turkish Variome for 4591 disease genes from PanelApp and OMIM, and identified 97,135 pathogenic and 478,263 likely pathogenic variants using an American College of Medical Genetics and Genomics-based classifier. This expanded pathogenic and likely pathogenic variants nearly six-fold. On average, an individual is born with 4.70 pathogenic or likely pathogenic variants, of which 1.66 are compatible with a Mendelian condition at the genotype level; 1 in 11 has an actionable genotype, and 382 genes are candidates for carrier screening. A genome-first approach revealed the likelihood of having a genotype compatible with disease in 13 ICD-10 disease groups, for example, congenital (1 in 2.70), musculoskeletal/connective (1 in 3.00) and blood/immune (1 in 3.07 individuals). Evidence-based genetic epidemiology demonstrates the potential of personalized medicine for the implementation of early preventive measures and incentivization of lifestyle changes to enhance healthspan and lifespan.

## Linked entities

- **Diseases:** congenital (MONDO:0021140)

## Full-text entities

- **Genes:** RYR1 (ryanodine receptor 1) [NCBI Gene 6261] {aka CCO, CMYO1A, CMYO1B, CMYP1A, CMYP1B, KDS}, ANO5 (anoctamin 5) [NCBI Gene 203859] {aka GDD1, LGMD2L, LGMDR12, TMEM16E}, LDLR (low density lipoprotein receptor) [NCBI Gene 3949] {aka LDLCQ2}, STAT1 (signal transducer and activator of transcription 1) [NCBI Gene 6772] {aka CANDF7, IMD31A, IMD31B, IMD31C, ISGF-3, STAT91}, KAT2B (lysine acetyltransferase 2B) [NCBI Gene 8850] {aka CAF, P/CAF, PCAF}, BTD (biotinidase) [NCBI Gene 686], NOTCH2 (notch receptor 2) [NCBI Gene 4853] {aka AGS2, HJCYS, hN2}, HFE (homeostatic iron regulator) [NCBI Gene 3077] {aka HFE1, HH, HLA-H, MVCD7, TFQTL2}, FLG (filaggrin) [NCBI Gene 2312] {aka ATOD2, FLG-1, FLG1}, KMT2D (lysine methyltransferase 2D) [NCBI Gene 8085] {aka AAD10, ALR, BCAHH, CAGL114, KABUK1, KMS}, TTN (titin) [NCBI Gene 7273] {aka CMD1G, CMH9, CMPD4, CMYO5, CMYP5, EOMFC}
- **Diseases:** inborn errors of metabolism (MESH:D008661), CrF (MESH:C563665), Gnathodiaphyseal dysplasia (MESH:C536039), LoF (MESH:D006315), cystic fibrosis (MESH:D003550), hemochromatosis (MESH:D006432), favism (MESH:D005236), cancer (MESH:D009369), LB (MESH:C537419), Malignant hyperthermia (MESH:D008305), Duchenne muscular dystrophy (MESH:D020388), nervous, congenital, respiratory, eye and neoplasm diseases (MESH:D012142), holoprosencephaly (MESH:D016142), AAVC (MESH:D019292), familial Mediterranean fever (MESH:D010505), AD diseases (MESH:D030342), nervous, and skin diseases (MESH:D012871), Yersinia pestis infections (MESH:D010930), diarrhea (MESH:D003967), hemoglobinopathies (MESH:D006453), alpha-thalassemia (MESH:D017085), skeletal disorders (MESH:C564967), thrombophilia (MESH:D019851), muscular dystrophy (MESH:D009136), familial hypercholesterolemia (MESH:D006938), Wilson disease (MESH:D006527), respiratory disease (MESH:D012140), nervous, neoplasm disease (MESH:D009423), malaria (MESH:D008288), palmoplantar keratoderma (MESH:D007645), pneumonia (MESH:D011014), deaths (MESH:D003643), RGC-ME (MESH:D008224), Miyoshi muscular dystrophy (MESH:C537480), P (MESH:D002972), dermatitis (MESH:D003872), spinal muscular atrophy (MESH:D009134), X-linked (MESH:C536424), GP (MESH:C563626), AD (MESH:C566739), Kabuki syndrome (MESH:C537705), VUS (MESH:D065309), biotinidase deficiency (MESH:D028921), Huntington disease (MESH:D006816), X-linked disorder (MESH:D040181), immune (MESH:D007154), dilated cardiomyopathy (MESH:D002311), AR (MESH:D020821)
- **Chemicals:** P (MESH:D010758), vitamin D (MESH:D014807), GP (-), PlP (MESH:D011732)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** C282Y, His63Asp

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13031552/full.md

---
Source: https://tomesphere.com/paper/PMC13031552